Compugen | CGEN - Current Assets


Compugen reported $148.02M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Arca Biopharma USD 343.86M 11.31M Dec/2025
aTyr Pharma USD 245.8M 152.79M Dec/2025
Bio Path USD 663K 17K Sep/2025
Brainstorm Cell Therapeutics USD 307K 201K Dec/2025
Cara Therapeutics USD 38.44M 4.69M Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
Immunic USD 39.27M 20.57M Sep/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
RedHill Biopharma USD 12.56M 644K Jun/2025
TherapeuticsMD USD 11.82M 303K Jun/2024